Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 3
1975 3
1976 4
1977 3
1978 2
1979 2
1980 3
1982 2
1984 1
1985 2
1986 3
1987 4
1988 2
1989 7
1990 4
1991 6
1992 8
1993 4
1994 11
1995 9
1996 15
1997 15
1998 27
1999 24
2000 35
2001 58
2002 62
2003 89
2004 102
2005 127
2006 162
2007 160
2008 186
2009 216
2010 293
2011 318
2012 342
2013 372
2014 344
2015 392
2016 379
2017 400
2018 367
2019 373
2020 370
2021 432
2022 374
2023 352
2024 337
2025 295
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,306 results

Results by year

Filters applied: . Clear all
Page 1
Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials (LIBERTY).
Hanauer SB, Sands BE, Schreiber S, Danese S, Kłopocka M, Kierkuś J, Kulynych R, Gonciarz M, Sołtysiak A, Smoliński P, Srećković S, Valuyskikh E, Lahat A, Horyński M, Gasbarrini A, Osipenko M, Borzan V, Kowalski M, Saenko D, Sardinov R, Lee SJ, Kim S, Bae Y, Lee S, Lee S, Lee JH, Yang S, Lee J, Lee J, Kim JM, Park G, Sandborn WJ, Colombel JF. Hanauer SB, et al. Among authors: kim jm. Gastroenterology. 2024 Oct;167(5):919-933. doi: 10.1053/j.gastro.2024.05.006. Epub 2024 May 23. Gastroenterology. 2024. PMID: 38788861 Free article. Clinical Trial.
Corrigendum.
Bae K, Lee BS, Kim JM, Bin SI, Lee J, Kim D, Jeon T. Bae K, et al. Among authors: kim jm. Bone Joint J. 2024 Jul 1;106-B(7):759. doi: 10.1302/0301-620X.106B7.BJJ-2024-00047. Bone Joint J. 2024. PMID: 38945533 No abstract available.
Subcutaneous infliximab (CT-P13 SC) as maintenance therapy for Crohn's disease and ulcerative colitis: 2-year results from open-label extensions of two randomized controlled trials (LIBERTY).
Colombel JF, Sandborn WJ, Schreiber S, Danese S, Kłopocka M, Kierkuś J, Kulynych R, Gonciarz M, Sołtysiak A, Smoliński P, Srećković S, Valuyskikh E, Lahat A, Horyński M, Gasbarrini A, Osipenko M, Borzan V, Kowalski M, Saenko D, Sardinov R, Lee SJ, Kim S, Bae Y, Lee S, Lee S, Lee JH, Kim JM, Park G, Lee J, Lee J, Ryu JY, Sands BE, Hanauer SB. Colombel JF, et al. Among authors: kim jm. J Crohns Colitis. 2025 Jun 4;19(6):jjaf060. doi: 10.1093/ecco-jcc/jjaf060. J Crohns Colitis. 2025. PMID: 40243842 Free PMC article. Clinical Trial.
[Fungal Infection in Upper Gastrointestinal Tract].
Lee A, Jung SW, Kim JM. Lee A, et al. Among authors: kim jm. Korean J Helicobacter Up Gastrointest Res. 2024 Jun;24(2):136-142. doi: 10.7704/kjhugr.2024.0029. Epub 2024 Jun 10. Korean J Helicobacter Up Gastrointest Res. 2024. PMID: 40502838 Free PMC article. Review. Korean.
6,306 results